Skin cancers or premalignant lesions occur in half of high‐dose PUVA patients

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British Journal of Dermatology

• Publication date

  1994-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1365-2133.1994.tb08494.xPMID 7917985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PUVA and cancer: a case‐control study

  1993cited by this paper
• Response of psoriasis to twice weekly PUVA

  1993cited by this paper
• PUVA and skin cancer. A historical cohort study on 492 patients.

  1992cited by this paper
• PUVA treatment of psoriasis in the United Kingdom

  1991cited by this paper
• PUVA and cancer: a large-scale epidemiological study.

  1991cited by this paper
• Psoriasis therapy and the risk of skin cancers

  1991cited by this paper
• PUVA and cancer: a large-scale epidemiological study

  1991cited by this paper
• “High single‐dose’ European PUVA regimen also causes an excess of non‐melanoma skin cancer

  1991cited by this paper
• Genital tumors among men with psoriasis exposed to PUVA.

  1990cited by this paper
• Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.

  1990cited by this paper
• Cutaneous malignancy in males treated with photochemotherapy.

  1990cited by this paper
• Genital tumors among men with psoriasis exposed to PUVA.

  1990cited by this paper
• Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment.

  1988cited by this paper
• Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.

  1987cited by this paper
• Skin tumors in the European PUVA Study

  1987cited by this paper
• The PUVA lentigo: an analysis of predisposing factors.

  1983cited by this paper
• Risk of carcinogenicity in patients with psoriasis treated with methotrexate or PUVA singly or in combination.

  1983cited by this paper
• Synergistic carcinogenic potential of methotrexate and PUVA in psoriasis.

  1983cited by this paper
• The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes.

  1983cited by this paper

• Heavy Metal Antagonists and Miscellaneous Drugs

  2021cites this paper
• Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities

  2021cites this paper
• Topical Therapy II: Retinoids, Immunomuodulators, and Others/Ultraviolet Therapy for Psoriasis

  2020cites this paper
• Comparison of two modalities of phototherapy, narrowband UV-B and PUVA in the treatment of psoriasis: A study from Western Uttar Pradesh

  2018cites this paper
• A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy

  2018cites this paper
• University of Dundee British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015

  2017cites this paper
• British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

  2016cites this paper
• "Eruptive Lentiginosis" in a Patient With Vitiligo and Inflammatory Bowel Disease Treated With Azathioprine.

  2016cites this paper
• Photodynamic therapy of the surface form of basalioma and actinic keratosis with the topical administration of methyl aminolevulinate

  2015cites this paper
• Phototherapy and photochemotherapy for psoriasis.

  2015cites this paper
• Cutaneous Carcinogenic Risk of Phototherapy: An Updated Comprehensive Review

  2015cites this paper
• Clinical efficacy of the rotation of phototherapy methods (PUVA therapy and mid-wavelength ultraviolet therapy (311 nm)) in patients with moderate to severe forms of psoriasis

  2015cites this paper
• Genetic Determinants of Skin Color, Aging, and Cancer

  2015cites this paper
• BASAL CELL CARCINOMA, SQUAMOUS CELL CARCINOMA, AND MELANOMA

  2014cites this paper
• Clinical manifestations of the skin photodamage as a result of a multi-course phototherapy of psoriasis patients

  2014cites this paper
• Evaluation of PUVA-Induced Skin Side Effects in Patients Referred to the Imam Reza Hospital of Mashhad in 2005-2007

  2014cites this paper
• Revisited the potential risks of carcinogenicity of phototherapy in patients with psoriasis

  2014cites this paper
• Ultraviolet Therapy for Psoriasis

  2014cites this paper
• Continuous versus intermittent therapy for moderate-to-severe psoriasis.

  2013cites this paper
• Actinic keratosis: a clinical and epidemiological revision.

  2012cites this paper
• Carcinogenic risks of Psoralen UV‐A therapy and Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review

  2012cites this paper
• The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida.

  2012cites this paper
• Glutathione S‐transferase genotype is associated with sensitivity to psoralen–ultraviolet A photochemotherapy

  2012cites this paper
• Identification of potentially cytotoxic lesions induced by UVA photoactivation of DNA 4-thiothymidine in human cells

  2011cites this paper
• Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.

  2010cites this paper
• 21 – Reactions to physical agents

  2010cites this paper
• 52. Non-Melanoma Skin Cancer and Other Epidermal Skin Tumours

  2010cites this paper
• Non‐Melanoma Skin Cancer and Other Epidermal Skin Tumours

  2008cites this paper
• Unintended benefits of immunosupression on autoimmune disease due to chemoradiation therapy for head and neck cancer.

  2008cites this paper
• Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen–ultraviolet A photochemotherapy

  2007cites this paper
• Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status

  2007influential citation
• The contribution of medical physics to the development of psoralen photochemotherapy (PUVA) in the UK: a personal reminiscence

  2006cites this paper
• The impacts of optical radiation in the environment on skin: Hazards, measurement, regulation and protection

  2006cites this paper
• Analysis of p53 Tumor Suppressor Gene, H-ras Protooncogene and Proliferating Cell Nuclear Antigen (PCNA) in Squamous Cell Carcinomas of HRA/Skh Mice Following Exposure to 8-Methoxypsoralen (8-MOP) and UVA Radiation (PUVA Therapy)

  2005cites this paper
• Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long‐term PUVA therapy

  2005cites this paper
• The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.

  2004cites this paper
• Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients

  2004cites this paper
• No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.

  2004influential citation
• Lentiginous eruption due to topical immunotherapy.

  2003cites this paper
• Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women

  2003cites this paper
• Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.

  2003cites this paper
• PHOTOTHERAPY (UVB) AND PHOTOCHEMOTHERAPY (PUVA) FOR PSORIASIS

  2002cites this paper
• The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.

  2002cites this paper
• Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

  2001cites this paper
• Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

  2001cites this paper
• Clinicopathologic Variants of Cutaneous Squamous Cell Carcinoma

  2001cites this paper
• Experimental contact sensitivity in patients with previous exposure to high-dose puva photochemotherapy.

  2001cites this paper
• Induction and excretion of ultraviolet-induced 8-oxo-2'-deoxyguanosine and thymine dimers in vivo: implications for PUVA.

  2001cites this paper
• PUVA-related punctate keratoses of the hands and feet.

  2000cites this paper
• p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.

  2000cites this paper
• Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy.

  2000cites this paper
• Atypical pigmented lesions following extensive PUVA therapy

  2000cites this paper
• Natural Toxins and Chemopreventives in Plants

  2000cites this paper
• Other Toxins in Edible Mushrooms Toxic Substances in Spices and Flavoring Agents Pyrrolizidine Alkaloids Substances in Bracken Fern Acetylcholinesterase Inhibitors in Potatoes Tannins Caffeic Acid and Chlorogenic Acid Coumarin and Psoralen Miscellaneous Flavonoids : Quercetin , Ellagic Acid , Kaempf

  2000cites this paper
• Melanoma in a psoriatic plaque.

  2000cites this paper
• Photothérapie et photochimiothérapie par ultraviolets

  1999cites this paper
• Arsenic-related Bowen's disease, palmar keratosis, and skin cancer.

  1999cites this paper
• Photo(chemo)therapy in private practice in Belgium, France and The Netherlands

  1999cites this paper
• A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis.

  1999cites this paper
• Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis

  1999cites this paper
• PUVA and cancer risk: the Swedish follow‐up study

  1999cites this paper
• Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy

  1999cites this paper
• Key developments in dermatology.

  1999cites this paper
• Urinary thymine dimers and 8‐oxo‐2′‐deoxyguanosine in psoriasis

  1999cites this paper
• Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy.

  1998cites this paper
• 5-Methoxypsoralen

  1998cites this paper
• Squamous cell cancer: a practical approach.

  1998cites this paper
• 5-Methoxypsoralen A Review of its Effects in Psoriasis and Vitiligo

  1998cites this paper
• Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers.

  1998cites this paper
• Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.

  1998cites this paper
• Consensus workshop on the toxic effects of long-term PUVA therapy.

  1998cites this paper
• Cutaneous manifestations of chronic arsenicism: review of seventeen cases.

  1998cites this paper
• 尋常性乾癬に重複癌 (有棘細胞癌・エックリン汗孔癌・食道癌) を合併した1例

  1997cites this paper
• A Case of Squamous Cell Carcinoma Arising From Psoriasis Vulgaris After Long-Term Phototherapy.

  1997cites this paper
• p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).

  1997cites this paper
• PUVA photocarcinogenesis in Cheshire

  1997cites this paper
• Ultraviolet Phototherapy

  1997cites this paper
• Response of PUVA-induced keratoses to etretinate.

  1996cites this paper
• Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.

  1996cites this paper
• Cutaneous neoplasia following PUVA therapy for psoriasis

  1996cites this paper
• PUVA, Psoralens and Skin Cancer

  1996cites this paper
• Drug-Induced Ocular Side Effects

  1996cites this paper
• Treatment of psoriasis with polyethylene sheet bath PUVA.

  1996cites this paper
• Are stress Proteins induced during PUVA therapy?

  1996cites this paper
• Skin cancer in transplant recipients

  1995cites this paper
• Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA

  1995cites this paper
• Dermatological drugs, topical drugs and cosmetics

  1994cites this paper